No Data
No Data
Mayinglong Pharmaceutical Group's MYL Ointment Gets Regulatory Approval for Clinical Trials
Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) Largest Shareholders Are Individual Investors Who Were Rewarded as Market Cap Surged CN¥664m Last Week
There Is A Reason Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) Price Is Undemanding
Mayinglong Pharmaceutical Group (SHSE:600993) Seems To Use Debt Rather Sparingly
Mayinglong Pharmaceutical Group (SHSE:600993) Stock Performs Better Than Its Underlying Earnings Growth Over Last Five Years
Calculating The Fair Value Of Mayinglong Pharmaceutical Group Co., Ltd. (SHSE:600993)
No Data